Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia
· Delayed Price · Currency is AUD 7.01
-0.34 (-4.63%)
Nov 7, 2024, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 2.24 billion as of November 7, 2024. Its market cap has increased by 757.21% in one year.
Market Cap
2.24B
Enterprise Value
2.11B
Revenue
11.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.01
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 2.24B, an increase of 484.25%. That is a compound annual growth rate of 73.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2024 | 2.35B | 372.36% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 137.51B |
| ResMed Inc. | 54.37B |
| Pro Medicus Limited | 20.36B |
| Fisher & Paykel Healthcare Corporation Limited | 19.44B |
| Cochlear Limited | 18.80B |
| Sonic Healthcare Limited | 12.79B |
| Ramsay Health Care Limited | 9.00B |
| Telix Pharmaceuticals Limited | 7.50B |